Transcat (NASDAQ:TRNS) Sets New 12-Month High at $117.63

Shares of Transcat, Inc. (NASDAQ:TRNS) hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $117.63 and last traded at $117.37, with a volume of 16240 shares traded. The stock had previously closed at $115.21.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on TRNS. HC Wainwright restated a “buy” rating and issued a $124.00 price target on shares of Transcat in a research note on Tuesday, April 16th. Oppenheimer reaffirmed an “outperform” rating and set a $125.00 price target (up from $120.00) on shares of Transcat in a research note on Thursday, April 18th. Finally, TheStreet upgraded shares of Transcat from a “c+” rating to a “b” rating in a research note on Wednesday, January 31st.

Transcat Stock Up 1.9 %

The company has a quick ratio of 2.81, a current ratio of 3.37 and a debt-to-equity ratio of 0.01. The firm’s fifty day simple moving average is $109.69 and its 200-day simple moving average is $103.62. The company has a market cap of $1.04 billion, a PE ratio of 88.62 and a beta of 0.61.

Insiders Place Their Bets

In other Transcat news, CEO Lee D. Rudow sold 2,373 shares of the business’s stock in a transaction on Saturday, March 30th. The stock was sold at an average price of $111.43, for a total value of $264,423.39. Following the completion of the transaction, the chief executive officer now directly owns 103,688 shares in the company, valued at approximately $11,553,953.84. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, Director Charles P. Hadeed sold 700 shares of the firm’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $113.00, for a total value of $79,100.00. Following the transaction, the director now directly owns 22,678 shares in the company, valued at approximately $2,562,614. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Lee D. Rudow sold 2,373 shares of the stock in a transaction dated Saturday, March 30th. The stock was sold at an average price of $111.43, for a total transaction of $264,423.39. Following the sale, the chief executive officer now owns 103,688 shares in the company, valued at approximately $11,553,953.84. The disclosure for this sale can be found here. 4.20% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Transcat

Hedge funds have recently made changes to their positions in the business. Rice Hall James & Associates LLC raised its stake in Transcat by 0.4% during the 1st quarter. Rice Hall James & Associates LLC now owns 27,472 shares of the scientific and technical instruments company’s stock valued at $3,061,000 after acquiring an additional 96 shares in the last quarter. Diversified Trust Co grew its position in Transcat by 4.3% in the 4th quarter. Diversified Trust Co now owns 2,435 shares of the scientific and technical instruments company’s stock valued at $266,000 after buying an additional 100 shares in the last quarter. White Pine Capital LLC increased its stake in Transcat by 1.5% during the 3rd quarter. White Pine Capital LLC now owns 9,985 shares of the scientific and technical instruments company’s stock valued at $978,000 after buying an additional 144 shares during the period. Commonwealth Equity Services LLC raised its position in shares of Transcat by 4.2% during the 3rd quarter. Commonwealth Equity Services LLC now owns 4,377 shares of the scientific and technical instruments company’s stock worth $429,000 after buying an additional 175 shares in the last quarter. Finally, Swiss National Bank lifted its stake in shares of Transcat by 1.2% in the 3rd quarter. Swiss National Bank now owns 16,815 shares of the scientific and technical instruments company’s stock worth $1,647,000 after acquiring an additional 200 shares during the period. Institutional investors own 98.34% of the company’s stock.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.